Abstract:Objective To compare the efficacy of latanoprost, travoprost and bimatoprost given in the evening on the 24-hour intraocular pressure (IOP) curve in open-angle glaucoma patients. Methods It was a case-control study. Patients with primary open-angle glaucoma were selected for the present study.Twenty-one, 22 and 20 patients were treated once daily with latanoprost, travoprost and bimatoprost for 4 weeks, respectively. Before and four weeks after the treatment, IOP was measured by masked evaluators at 8AM, 10AM, noon, 2PM, 4PM, 6PM, 8PM, 10PM, midnight, 2AM, 4AM and 6AM. Repeated measure analysis of variance was used to compare the IOP responses to the drug regimens for the entire circadian curve. Analysis of variance was used to compare the circadian variations of intraocular pressure. Results The IOPs of all patients in these 3 groups decreased markedly after 4 weeks. The daily average IOP ( mean ±standard deviation) in the latanoprost group decreased from ( 18.9 ± 2. 1 ) mm Hg ( 1 mm Hg = 0. 133 kPa)to ( 15.3 ±2. 7) mm Hg, and the extent of the decrease was 19. 0％. IOP in the travoprost group decreased from ( 19. 1 ± 3. 1 ) mm Hg to ( 15. 3 ± 2. 1 ) mm Hg , with a decrease of 19.4 ％. IOP in the bimatoprost group decreased from ( 18. 6 ± 1.9 ) mm Hg to ( 14. 9 ± 1.9 ) mm Hg, with a decrease of 19.9％. The effectiveness of the treatments did not differ significantly between these three groups ( F = 1. 501, P =0. 110). The descending percentage compared with circadian variation ranges before treatment in patients with latanoprost, travoprost and bimatoprost was 31.0％, 31. 1％ and 31.9％, respectively. In comparison of these three groups, the circadian variations of intraocular pressure did not differ significantly( F = 0. 286,P = 0. 752). Conclusions This study demonstrated that latanoprost, travoprost and bimatoprost are all effective in reducing IOP over the 24-hour curve in primary open-angle glaucoma. On the basis of our data,there was no statistically significant difference in the IOP reduction between these three drugs.

Pharmaco-economic Analysis of Applying Prostaglandins Analogue for the Treatment of ;Glaucoma

Cost-effectiveness analysis of tafluprost versus latanoprost in the treatment of primary open-angle glaucoma

Consideration of Several Problems in Clinical Application of Prostaglandin Analogues in Lowering Intraocular Pressure

Therapeutic uses of prostaglandin F2α analogues in ocular disease and novel synthetic strategies

Comparison of Latanoprost and Brimonidine in the Treatment of Open Angle Glaucoma

Evaluation of Generic versus Original Prostaglandin Analogues in the Treatment of Glaucoma: A Systematic Review and Meta-Analysis

A Comparison of the Ocular Hypotensive Efficacy of Three Prostaglandin Analogs

Effects of Four Formulations of Prostaglandin Analogs on Eye Surface Cells. A Comparative Study

Investigational drugs targeting prostaglandin receptors for the treatment of glaucoma

Effectiveness and Safety of Tafluprost in Primary Open-Angle Glaucoma and Ocular Hypertension: a Post-Marketing Phase IV Study in China

Meta-analysis of randomized controlled trials comparing latanoprost with timolol in the treatment of Asian populations with chronic angle-closure glaucoma.

Meta-analysis of the Efficacy and Safety of Latanoprost Monotherapy in Patients With Angle-closure Glaucoma.

A Review of Clinical Trials of Tafluprost versus Latanoprost for the Treatment of Primary Open-angle Glaucoma

Tafluprost for glaucoma

Pharmacoeconomic Evaluation of Tamsulosin Hydrochloride Sustained-release Capsules in the Treatment of Benign Prostatic Hyperplasia

Comparison of Intraocular Pressure Reducing Effects of Three Prostaglandin Eyedrops in Open-Angle Glaucoma

Prostaglandin FP receptor agonists in the treatment of glaucoma and ocular hypertension: a literature review

Changes of the Types and Daily Costs of Topical Antiglaucoma Medications from 2006 to 2021 in China

Cost-utility analysis of commonly used anti-glaucoma interventions for mild-to-moderate primary open-angle glaucoma patients in rural and urban China

Cost-minimization Analysis of 2 Drug Therapy Projects Including Traditional Chinese Medcines and Chemical Medcines in BPH Patients

Intraocular Pressure Lowering Efficacy and Safety of Travoprost 0.004% As A Replacement Therapy in Patients with Open Angle Glaucoma or Ocular Hypertension